SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
17-Jan-24 5:31 PM View: | Adaptimmune Therapeutics plc (ADAP) | 17-Jan-24 | Sale | 18,276 | $0.67 | $12,299.70 | (49%) 37.53K to 19.26K | |
17-Jan-24 5:31 PM View: | Adaptimmune Therapeutics plc (ADAP) | 16-Jan-24 | Sale | 2,287 | $0.79 | $1,806.73 | (40%) 5.65K to 3.36K | |
12-Jan-24 5:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-24 | Sale | 7,799 | $0.85 | $6,661.13 | (40%) 19.64K to 11.84K | |
12-Jan-24 5:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-24 | Sale | 4,009 | $0.84 | $3,354.33 | (40%) 10.11K to 6.1K | |
17-Jan-23 9:16 PM View: | Adaptimmune Therapeutics plc (ADAP) | 17-Jan-23 | Sale | 2,159 | $1.86 | $4,011.42 | (38%) 5.65K to 3.49K | |
12-Jan-23 9:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-23 | Sale | 7,449 | $1.71 | $12,708.00 | (38%) 19.64K to 12.19K | |
12-Jan-23 9:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-23 | Sale | 3,843 | $1.75 | $6,712.95 | (38%) 10.11K to 6.27K | |
04-Jan-23 9:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 04-Jan-23 | Sale | 876 | $1.69 | $1,483.94 | (39%) 2.24K to 1.36K | |
18-Jan-22 9:02 PM View: | Adaptimmune Therapeutics plc (ADAP) | 18-Jan-22 | Market Sale | 2,121 | $3.19 | $6,769.81 | (38%) 5.65K to 3.53K | (9%) |
13-Jan-22 9:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-22 | Market Sale | 854 | $3.54 | $3,026.66 | (38%) 2.24K to 1.38K | 2% |
13-Jan-22 9:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 11-Jan-22 | Market Sale | 3,770 | $3.56 | $13,408.80 | (37%) 10.11K to 6.34K | 2% |
05-Jan-22 9:05 PM View: | Adaptimmune Therapeutics plc (ADAP) | 04-Jan-22 | Market Sale | 849 | $4.06 | $3,450.51 | (38%) 2.24K to 1.39K | 6% |
19-Jan-21 9:01 PM View: | Adaptimmune Therapeutics plc (ADAP) | 19-Jan-21 | Market Sale | 2,111 | $5.67 | $11,968.30 | (37%) 5.65K to 3.54K | (< 1%) |
12-Jan-21 9:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 12-Jan-21 | Market Sale | 841 | $6.15 | $5,174.00 | (38%) 2.24K to 1.4K | (1%) |
05-Jan-21 9:00 PM View: | Adaptimmune Therapeutics plc (ADAP) | 04-Jan-21 | Market Sale | 845 | $5.33 | $4,502.08 | (38%) 2.24K to 1.39K | (13%) |
15-Jan-20 8:03 PM View: | Adaptimmune Therapeutics plc (ADAP) | 14-Jan-20 | Market Sale | 911 | $5.13 | $4,677.71 | (41%) 2.24K to 1.33K | (4%) |